Regencell Bioscience Holdings Limited (RGC) NASDAQ
23.15
-1.02(-4.22%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 8.43B |
| Enterprise Value | 8.42B |
| P/E Ratio | -1,624.07 |
| PEG Ratio | -18.07 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 9,387.88 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -1,628.03 |
Fiscal Year
| Fiscal Year | June 30, 2025 |
| Most Recent Quarter | December 31, 2025 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
Management Effectiveness
| Return On Assets | -2.34 |
| Return On Equity | -2.32 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -392,743 |
| EBITDA | -3.19M |
| Net Income | -3.58M |
| Diluted EPS | -0.01 |
Balance Sheet
| Total Cash | 2.36M |
| Total Cash/Share | 0 |
| Total Debt | 386,301 |
| Total Debt/Equity | 0.32 |
| Current Ratio | 1.42 |
| Book Value Per Share | 0 |
Price History
| 52-Week Change | 17.63 |
| 52-Week High | 83.6 |
| 52-Week Low | 9.39 |
| Moving Average 50 Days | 27.66 |
| Moving Average 200 Days | 22.05 |
Statistics
| Average Volume | 132,538 |
| Shares Outstanding | 494.49M |
| % Held by Institutions | 0.13 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 38:1 |
| Last Split Date | June 16, 2025 |
